Literature DB >> 6375930

Sex-related differences in drug disposition in man.

K Wilson.   

Abstract

Sex-related differences in the disposition of some analgesics, anxiolytics and hypnotics have recently been reported. With certain benzodiazepines, sex has been shown to be a more important determinant of variability in drug disposition than age, while with other benzodiazepines an age-related decline in clearance was more pronounced in men than women. In young healthy adults these sex-related differences in drug disposition were related to the phase of the menstrual cycle, oral contraceptive steroid administration, and variations in plasma concentrations of albumin, alpha 1-acid glycoprotein, free fatty acids and sex hormones. While none of the sex-related differences so far reported necessitates the modification of a therapeutic dosage regimen, it is prudent that future protocols for pharmacokinetic studies should regard age, sex, the menstrual cycle and oral contraceptive steroids as potential sources of variability.

Entities:  

Keywords:  Age Factors; Alcohol Drinking; Anesthesia--pharmacodynamics; Behavior; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Demographic Factors; Diseases; Drugs--pharmacodynamics; Family Planning; Hepatic Effects; Literature Review; Menstrual Cycle; Menstruation; Metabolic Effects; Oral Contraceptives; Physiology; Population; Population Characteristics; Reproduction; Sex Factors; Social Behavior; Treatment

Mesh:

Substances:

Year:  1984        PMID: 6375930     DOI: 10.2165/00003088-198409030-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  93 in total

1.  Effect of hypophysectomy and pituitary implants at puberty on the sexual differentiation of testosterone metabolism in rat liver.

Authors:  C Denef
Journal:  Endocrinology       Date:  1974-06       Impact factor: 4.736

2.  [Level of rifampicine in human serum].

Authors:  G Porven; G Canetti
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1968 Jul-Aug

3.  Variability of beta-blocker pharmacokinetics in young volunteers.

Authors:  D B Jack; C P Quarterman; R Zaman; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Differential effects of enzyme induction on antipyrine metabolite formation.

Authors:  M Danhof; R M Verbeek; C J van Boxtel; J K Boeijinga; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

5.  Comparison of gastric emptying and secretion in men and women with reference to prevalence of duodenal ulcer in each sex.

Authors:  M BOOTH; J N HUNT; J M MILES; F A MURRAY
Journal:  Lancet       Date:  1957-03-30       Impact factor: 79.321

6.  Effect of age and gender on disposition of temazepam.

Authors:  M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

7.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

8.  Antipyrine disposition in milk and saliva of lactating women.

Authors:  C M Berlin; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

9.  The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

Authors:  K Wilson; M Oram; C E Horth; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

10.  Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.

Authors:  U Abshagen; S Spörl-Radun; J Marinow
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

View more
  32 in total

1.  Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin.

Authors:  H Cheng; J D Rogers; A E Sweany; M R Dobrinska; E A Stein; A C Tate; R D Amin; H Quan
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

Review 2.  [Gender aspects in anesthesia : modified approach in research and treatment?].

Authors:  M Schopper; P I Bäumler; J Fleckenstein; D Irnich
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

Review 3.  [Gender differences in acute and chronic pain conditions. Implications for diagnosis and therapy].

Authors:  M Schopper; J Fleckenstein; D Irnich
Journal:  Schmerz       Date:  2013-09       Impact factor: 1.107

4.  Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.

Authors:  M Contin; R Riva; P Martinelli; F Albani; A Baruzzi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  Bioequivalence assessment of generic drugs: an American point of view.

Authors:  R Patnaik; L J Lesko; K Chan; R L Williams
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 6.  Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype.

Authors:  A Llerena; J Cobaleda; C Martínez; J Benítez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

7.  Adverse drug reaction reporting in a pharmacovigilance centre of Nepal.

Authors:  N Jha; P R Shankar; O Bajracharya; S B Gurung; K K Singh
Journal:  Australas Med J       Date:  2012-05-31

8.  Gender differences in the pharmacodynamics of barbiturates in rats.

Authors:  A Hoffman; G Levy
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

9.  Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in Rats.

Authors:  Jennypher Mudunuru; Chen Ren; David R Taft; Manoj Maniar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-08       Impact factor: 2.441

Review 10.  Clinical pharmacokinetics of mibefradil.

Authors:  H A Welker; H Wiltshire; R Bullingham
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.